Namita Thapar, Whole Time Director, Emcure Pharmaceuticals along with Satish Mehta, MD & CEO, Emcure Pharmaceuticals gives insights on Emcure's IPO Issue opening on July 3 and explains why their profits went down in FY24.
#emcurepharma #pharma #ndtvprofit
For more videos subscribe to our channel: [ Ссылка ]
Visit NDTV Profit for more news: [ Ссылка ]
Don't enter the stock market unaware. Read all Research Reports here: [ Ссылка ]
Follow NDTV Profit here
Twitter: [ Ссылка ] , [ Ссылка ]
LinkedIn: [ Ссылка ]
Instagram: [ Ссылка ]
Facebook: [ Ссылка ]
